A Validated NMR Approach for MDMA Quantification in Ecstasy Tablets

被引:20
|
作者
Almeida, Nathalia S. [1 ]
Benedito, Luiz E. C. [1 ]
Maldaner, Adriano O. [2 ]
de Oliveira, Aline L. [1 ]
机构
[1] Univ Brasilia, Inst Quim, BR-70910900 Brasilia, DF, Brazil
[2] Policia Fed, Inst Nacl Criminalist, SAIS Quadra 07 Lote 23, BR-70610200 Brasilia, DF, Brazil
关键词
ecstasy; MDMA; qNMR; forensic analysis; validation; SPECTROSCOPY;
D O I
10.21577/0103-5053.20180071
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In recent years, ecstasy trafficking has grown in complexity and tablets has been commonly sold containing different contents of 3,4-methylenedioxymethamphetamine (MDMA) or even other psychoactive substances. In contrast, identification and quantification of drugs of abuse is still a challenge, once the access to drug standards is very restricted in Brazil. In this work, ecstasy tablets seized by the Brazilian Federal Police have their chemical composition identified and quantified by gas chromatography and quantitative H-1 nuclear magnetic resonance based on an internal standard approach (IS-H-1-qNMR). Both methods were validated and showed suitable results for the figures of merit. IS-H-1-qNMR shows excellent results of accuracy (relative error < 5%) and precision (relative standard deviation (RSD) < 2%). Comparatively, IS-H-1-qNMR is more efficient and versatile than gas chromatography to accomplish in a single analysis the identification and quantification of target analytes. Since the method does not require a specific reference material, it is cost effective and provides agility to routine forensic analysis.
引用
收藏
页码:1944 / 1950
页数:7
相关论文
共 50 条
  • [41] Neurotoxic Effects of MDMA (Ecstasy) on the Developing Rodent Brain
    Dzietko, M.
    Sifringer, M.
    Klaus, J.
    Endesfelder, S.
    Brait, D.
    Hansen, H. H.
    Bendix, I.
    Felderhoff-Mueser, U.
    DEVELOPMENTAL NEUROSCIENCE, 2010, 32 (03) : 197 - 207
  • [42] The Variability of Ecstasy Tablets Composition in Brazil
    Togni, Loraine R.
    Lanaro, Rafael
    Resende, Rodrigo R.
    Costa, Jose L.
    JOURNAL OF FORENSIC SCIENCES, 2015, 60 (01) : 147 - 151
  • [43] DETERMINATION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN ECSTASY TABLETS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION (HPLC-FD)
    da Costa, Jose Luiz
    Pintao, Estela Regina
    Castro Corrigliano, Celia Maria
    Negrini Neto, Osvaldo
    QUIMICA NOVA, 2009, 32 (04): : 965 - 969
  • [44] MDMA (Ecstasy) use and psychiatric problems
    Casey R. Guillot
    Mitchell E. Berman
    Psychopharmacology, 2007, 189 : 575 - 576
  • [45] Ecstasy (MDMA): A rebellion coherent with the system
    Garcia-Montes, Jose Manuel
    Perez-Alvarez, Marino
    Sanchez-Moya, Miguel Angel
    Carmona Torres, Jose Alberto
    Carreno, David F.
    Perona Garcelan, Salvador
    Sanchez-Sanchez, Laura Carmen
    NORDIC STUDIES ON ALCOHOL AND DRUGS, 2021, 38 (01) : 89 - 102
  • [46] An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine
    Downey, C.
    Daly, F.
    O'Boyle, K. M.
    TOXICOLOGY IN VITRO, 2014, 28 (02) : 231 - 239
  • [47] Subjective ratings of prospective memory deficits in MDMA ('ecstasy') users
    Heffernan, TM
    Ling, J
    Scholey, AB
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (04) : 339 - 344
  • [48] Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release
    Fallon, JK
    Shah, D
    Kicman, AT
    Hutt, AJ
    Henry, JA
    Cowan, DA
    Forsling, M
    CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE II: COCAINE, SUBSTITUTED AMPHETAMINES, GHB, AND OPIATES, 2002, 965 : 399 - 409
  • [49] Increased cortisol levels in hair of recent Ecstasy/MDMA users
    Parrott, A. C.
    Sands, H. R.
    Jones, L.
    Clow, A.
    Evans, P.
    Downey, L. A.
    Stalder, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (03) : 369 - 374
  • [50] Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users
    Jones, Katy A.
    Blagrove, M.
    Parrott, A. C.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2009, 41 (04) : 323 - 329